You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Drugs for Chronic Obstructive Pulmonary Disorder Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot
The global Drugs for Chronic Obstructive Pulmonary Disorder market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs for Chronic Obstructive Pulmonary Disorder by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Short-Acting Bronchodilators
Corticosteroids
Methylxanthines
Long-Acting Bronchodilators
Phosphodiesterase-4 Inhibitors
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AstraZeneca
Boehringer Ingelheim
GSK
Novartis
Teva Pharmaceuticals
Ache Laboratorios Farmaceuticos
Almirall
Aquinox Pharmaceuticals
Ario Pharma
Asmacure
Astellas Pharma
BioMarck Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
GOLD 1? FEV1 ? 80%
GOLD 2? 50% ? FEV1 < 80%
GOLD 3? 30% ? FEV1 < 50%
GOLD 4? FEV1 < 30%
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Drugs for Chronic Obstructive Pulmonary Disorder Industry
Figure Drugs for Chronic Obstructive Pulmonary Disorder Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Drugs for Chronic Obstructive Pulmonary Disorder
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Drugs for Chronic Obstructive Pulmonary Disorder
1.2.2 Downstream
Table Application Segment of Drugs for Chronic Obstructive Pulmonary Disorder
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Drugs for Chronic Obstructive Pulmonary Disorder Market by Type
3.1 By Type
3.1.1 Short-Acting Bronchodilators
Table Major Company List of Short-Acting Bronchodilators
3.1.2 Corticosteroids
Table Major Company List of Corticosteroids
3.1.3 Methylxanthines
Table Major Company List of Methylxanthines
3.1.4 Long-Acting Bronchodilators
Table Major Company List of Long-Acting Bronchodilators
3.1.5 Phosphodiesterase-4 Inhibitors
Table Major Company List of Phosphodiesterase-4 Inhibitors
3.2 Market Size
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Market 2016-2020, by Type, in USD Million
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Market Growth 2016-2020, by Type, in USD Million
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Market 2016-2020, by Type, in Volume
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Market Forecast 2021-2026, by Type, in USD Million
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 AstraZeneca (Company Profile, Sales Data etc.)
4.1.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.1.2 AstraZeneca Products & Services
4.1.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.2.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.2.2 Boehringer Ingelheim Products & Services
4.2.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 GSK (Company Profile, Sales Data etc.)
4.3.1 GSK Profile
Table GSK Overview List
4.3.2 GSK Products & Services
4.3.3 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Novartis (Company Profile, Sales Data etc.)
4.4.1 Novartis Profile
Table Novartis Overview List
4.4.2 Novartis Products & Services
4.4.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Teva Pharmaceuticals (Company Profile, Sales Data etc.)
4.5.1 Teva Pharmaceuticals Profile
Table Teva Pharmaceuticals Overview List
4.5.2 Teva Pharmaceuticals Products & Services
4.5.3 Teva Pharmaceuticals Business Operation Conditions
Table Business Operation of Teva Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Ache Laboratorios Farmaceuticos (Company Profile, Sales Data etc.)
4.6.1 Ache Laboratorios Farmaceuticos Profile
Table Ache Laboratorios Farmaceuticos Overview List
4.6.2 Ache Laboratorios Farmaceuticos Products & Services
4.6.3 Ache Laboratorios Farmaceuticos Business Operation Conditions
Table Business Operation of Ache Laboratorios Farmaceuticos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Almirall (Company Profile, Sales Data etc.)
4.7.1 Almirall Profile
Table Almirall Overview List
4.7.2 Almirall Products & Services
4.7.3 Almirall Business Operation Conditions
Table Business Operation of Almirall (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Aquinox Pharmaceuticals (Company Profile, Sales Data etc.)
4.8.1 Aquinox Pharmaceuticals Profile
Table Aquinox Pharmaceuticals Overview List
4.8.2 Aquinox Pharmaceuticals Products & Services
4.8.3 Aquinox Pharmaceuticals Business Operation Conditions
Table Business Operation of Aquinox Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Ario Pharma (Company Profile, Sales Data etc.)
4.9.1 Ario Pharma Profile
Table Ario Pharma Overview List
4.9.2 Ario Pharma Products & Services
4.9.3 Ario Pharma Business Operation Conditions
Table Business Operation of Ario Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Asmacure (Company Profile, Sales Data etc.)
4.10.1 Asmacure Profile
Table Asmacure Overview List
4.10.2 Asmacure Products & Services
4.10.3 Asmacure Business Operation Conditions
Table Business Operation of Asmacure (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Astellas Pharma (Company Profile, Sales Data etc.)
4.11.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
4.11.2 Astellas Pharma Products & Services
4.11.3 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 BioMarck Pharmaceuticals (Company Profile, Sales Data etc.)
4.12.1 BioMarck Pharmaceuticals Profile
Table BioMarck Pharmaceuticals Overview List
4.12.2 BioMarck Pharmaceuticals Products & Services
4.12.3 BioMarck Pharmaceuticals Business Operation Conditions
Table Business Operation of BioMarck Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Revenue 2016-2020, by Company, in USD Million
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Revenue Share in 2020, by Company, in USD Million
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Volume 2016-2020, by Company, in Volume
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Drugs for Chronic Obstructive Pulmonary Disorder Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Drugs for Chronic Obstructive Pulmonary Disorder Market Concentration, in 2020
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Market Concentration, in 2020
Figure Asia-Pacific Drugs for Chronic Obstructive Pulmonary Disorder MMarket Concentration, in 2020
Figure South America Drugs for Chronic Obstructive Pulmonary Disorder Market Concentration, in 2020
Figure Middle East & Africa Drugs for Chronic Obstructive Pulmonary Disorder Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in GOLD 1? FEV1 ? 80%
Figure Drugs for Chronic Obstructive Pulmonary Disorder Demand in GOLD 1? FEV1 ? 80%, 2016-2020, in USD Million
Figure Drugs for Chronic Obstructive Pulmonary Disorder Demand in GOLD 1? FEV1 ? 80%, 2016-2020, in Volume
6.1.2 Demand in GOLD 2? 50% ? FEV1 < 80%
Figure Drugs for Chronic Obstructive Pulmonary Disorder Demand in GOLD 2? 50% ? FEV1 < 80%, 2016-2020, in USD Million
Figure Drugs for Chronic Obstructive Pulmonary Disorder Demand in GOLD 2? 50% ? FEV1 < 80%, 2016-2020, in Volume
6.1.3 Demand in GOLD 3? 30% ? FEV1 < 50%
Figure Drugs for Chronic Obstructive Pulmonary Disorder Demand in GOLD 3? 30% ? FEV1 < 50%, 2016-2020, in USD Million
Figure Drugs for Chronic Obstructive Pulmonary Disorder Demand in GOLD 3? 30% ? FEV1 < 50%, 2016-2020, in Volume
6.1.4 Demand in GOLD 4? FEV1 < 30%
Figure Drugs for Chronic Obstructive Pulmonary Disorder Demand in GOLD 4? FEV1 < 30%, 2016-2020, in USD Million
Figure Drugs for Chronic Obstructive Pulmonary Disorder Demand in GOLD 4? FEV1 < 30%, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Drugs for Chronic Obstructive Pulmonary Disorder Demand Forecast 2021-2026, by Application, in USD Million
Figure Drugs for Chronic Obstructive Pulmonary Disorder Market Growth 2021-2026, by Application, in USD Million
Figure Drugs for Chronic Obstructive Pulmonary Disorder Market Share in 2026, by Application, in USD Million
Table Drugs for Chronic Obstructive Pulmonary Disorder Demand Forecast 2021-2026, by Application, in Volume
Table Drugs for Chronic Obstructive Pulmonary Disorder Market Growth 2021-2026, by Application, in Volume
Table Drugs for Chronic Obstructive Pulmonary Disorder Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Drugs for Chronic Obstructive Pulmonary Disorder Production 2016-2020, by Region, in USD Million
Table Drugs for Chronic Obstructive Pulmonary Disorder Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Market 2016-2020, by Region, in USD Million
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Market Share 2016-2020, by Region, in USD Million
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Market 2016-2020, by Region, in Volume
Table Global Drugs for Chronic Obstructive Pulmonary Disorder Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in USD Million
Figure North America Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in USD Million
Table North America Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in USD Million
Figure Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in USD Million
Table Europe Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in USD Million
Figure South America Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in USD Million
Table South America Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Drugs for Chronic Obstructive Pulmonary Disorder Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Drugs for Chronic Obstructive Pulmonary Disorder Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Drugs for Chronic Obstructive Pulmonary Disorder Market Forecast 2021-2026, by Region, in USD Million
Table Drugs for Chronic Obstructive Pulmonary Disorder Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 92